Friday, November 08
|
Session Title |
Speaker(s) |
Primary Track |
Presentation Format |
6:15 AM - 7:30 AM
|
AACA 2019: Subcutaneous Versus Sublingual Allergen Immunotherapy – Where Do We Stand in 2019?
Supported by an independent educational grant from ALK – Abello Inc
This program will provide an up-to-date review of recent studies supporting the use of allergen immunotherapy for allergic rhinitis and allergic asthma, allowing the attendee to be fully versed on recent studies related to the mechanism, efficacy and safety of both subcutaneous and sublingual immunotherapy. Issues impacting clinical practice will be reviewed, including patient adherence, patient selection and mitigating factors in favor of particular immunotherapy formats, based on both U.S. and international published data.
Moderator: Warner W. Carr, MD, FACAAI
6:15 am
Welcome and Introductions
Warner W. Carr, MD, FACAAI
6:20 am
The Current Use of SCIT Versus SLIT – US and Internationally: A Survey of the Landscape of Allergen-specific Immunotherapy Worldwide
Moises Calderon-Zapata, MD, PhD
6:40 am
Efficacy of SLIT Tablets in Pollen Allergy and Dust Allergy: A Review of the Literature Related to Allergic Rhinitis and Asthma Which Has Led to FDA and International Regulatory Approvals
Lawrence M. DuBuske, MD, FACAAI
7:00 am
Comparative Safety of SLIT Versus SCIT: A Recent Appraisal of Adverse Events and Fatalities
Russell Settipane, MD, FACAAI
7:20 am
Questions and Discussion
|
|
Moderator:
Warner W. Carr, MD, FACAAI
Speaker:
Moises Calderon-Zapata, MD, PhD
Speaker:
Lawrence M. DuBuske, MD, FACAAI
Speaker:
Russell Settipane, MD, FACAAI
|
Immunotherapy and Diagnostics
|
Symposium
|
6:45 AM - 7:30 AM
|
SPARK Welcome Program (Invitation Only)
|
|
Fellows-in-Training
|
|
8:00 AM - 9:30 AM
|
Idiopathic Anaphylaxis – Knowledge Gaps and Patient Needs
This symposium will help the learner know what to investigate when referred a patient for anaphylaxis and no obvious trigger can be identified. The attendee will leave with a good approach to the differential diagnosis of recurrent idiopathic anaphylaxis and be able to initiate the appropriate management strategy for the same.
Moderators: Anne K. Ellis, MD, MSc, FACAAI, and Nicole M. Chase, MD, FACAAI
8:00 am
Welcome and Introductions
Anne K. Ellis, MD, MSc, FACAAI
Nicole M. Chase, MD, FACAAI
8:05 am
Idiopathic Anaphylaxis – Prevalence and Presentation
Jay A. Lieberman, MD, FACAAI
8:30 am
The Genetics, Biomarkers and Phenotypes of Idiopathic Anaphylaxis
Paul A. Greenberger, MD, FACAAI
8:55 am
Overlap Between Mast Cell Disorders and Anaphylaxis
Phillip L. Lieberman, MD, FACAAI
9:20 am
Questions and Discussion
|
|
Moderator:
Anne K. Ellis, MD, MSc, FACAAI
Moderator:
Nicole M. Chase, MD
Speaker:
Jay A. Lieberman, MD, FACAAI
Speaker:
Paul A. Greenberger, MD, FACAAI
Speaker:
Phillip L. Lieberman, MD, FACAAI
|
Rhinitis / Sinusitis / Ocular and Anaphylaxis
|
Symposium
|
Phases of Allergy Practice
Limit 54. Seats Available on first-come, first-served basis.
Whether you are just getting started or a seasoned veteran, this exciting interactive learning opportunity has something for you. Choose three of the six topics and spend 25 minutes with each expert addressing a phase of allergy practice. The expert will give a five-minute overview of the topic and will then answer questions and facilitate discussion with the table participants for 20 minutes.
Table Rotations: 8:05 am, 8:30 am, 9:00 am
Moderator: Kevin P. McGrath, MD, FACAAI
8:00 am
Welcome and Introductions
Kevin P. McGrath, MD, FACAAI
Table 1
Academic Practice Versus Private Practice
Kathleen R. May, MD, FACAAI
Table 2
Joining a Practice or Starting Your Own Practice
William E. Berger, MD, MBA, FACAAI
Table 3
Expanding a Practice
James L. Sublett, MD, FACAAI
Table 4
Working With Nurse Practitioners and/or Physician Assistants
Melinda M. Rathkopf, MD, FACAAI
Table 5
Retirement Planning
Stanley M. Fineman, MD, MBA, FACAAI
Table 6
Selling a Practice / Transitioning Out of a Practice
Dana V. Wallace, MD, FACAAI
|
|
Moderator:
Kevin P. McGrath, MD, FACAAI
Speaker:
Kathleen R. May, MD, FACAAI
Speaker:
William E. Berger, MD, MBA, FACAAI
Speaker:
James L. Sublett, MD, FACAAI
Speaker:
Melinda M. Rathkopf, MD, FACAAI
Speaker:
Stanley M. Fineman, MD, MBA, FACAAI
Speaker:
Dana V. Wallace, MD, FACAAI
|
Practice Management / Professional Issues
|
Ask the Expert Roundtables
|
10:00 AM - 11:30 AM
|
Across the Spectrum of Immunotherapy
For some patients, use of rush or cluster immunotherapy can result in greater adherence and ultimate success. Identifying this patient population and preparing for potential side effects and practical impediments to their use of immunotherapy is essential in comprehensive allergy care.
Moderator: Ira Finegold, MD, FACAAI, and Joseph P. Forester, DO, FACAAI
10:00 am
Welcome and Introductions
Ira Finegold, MD, FACAAI
Joseph P. Forester, DO, FACAAI
10:05 am
Cluster and Rush: How Does It Differ From Standard IT?
Jay M. Portnoy, MD, FACAAI
10:25 am
Identifying Appropriate Patients for Different Types of AIT
John J. Oppenheimer, MD, FACAAI
10:45 am
Practical Issues That May Impede Success of AIT
Michael Tankersley, MD, MBA, FACAAI
11:05 am
Evidence-based Use of SLIT
Moises Calderon-Zapata, MD, PhD
11:20 am
Questions and Discussion
|
|
Moderator:
Ira Finegold, MD, FACAAI
Moderator:
Joseph P. Forester, DO, FACAAI
Speaker:
Jay M. Portnoy, MD, FACAAI
Speaker:
John J. Oppenheimer, MD, FACAAI
Speaker:
Mike Tankersley, MD, MBA, FACAAI
Speaker:
Moises Calderon-Zapata, MD, PhD
|
Immunotherapy and Diagnostics
|
Symposium
|
Biologics for the Young and the Restless
Biologic therapy is increasingly important in the armamentarium of the allergist/immunologist. New biologics have been approved for treatment of severe asthma, atopic dermatitis and CRS, and new indications are being investigated, including food allergy.
Moderators: Jay A. Lieberman, MD, FACAAI, and William C. Anderson, MD, FACAAI
10:00 am
Welcome and Introductions
Jay A. Lieberman, MD, FACAAI
William C. Anderson, MD, FACAAI
10:05 am
Biologics: How to Choose the Right One for Asthma
Jonathan Corren, MD, FACAAI
10:30 am
Beyond Asthma: Biologics in Adults
Thomas B. Casale, MD, FACAAI
10:55 am
Biologics in Pediatrics
Carla M. Davis, MD, FACAAI
11:20 am
Questions and Discussion
|
|
Moderator:
Jay A. Lieberman, MD, FACAAI
Moderator:
William C. Anderson, MD
Speaker:
Jonathan Corren, MD, FACAAI
Speaker:
Thomas B. Casale, MD, FACAAI
Speaker:
Carla M. Davis, MD, FACAAI
|
Asthma and Respiratory / Sleep Disorders
|
Symposium
|
11:30 AM - 12:55 PM
|
Implementing Food Allergy Therapy in Clinical Practice (Luncheon Symposium)
Supported by an independent educational grant from Aimmune Therapeutics
This symposium has been designed to aid attendees in their efforts to align their practice with current guidelines and expert recommendations and ensure that they are aware of the full complement of therapeutic options for helping patients manage their food allergies. In doing so, session participants will be better positioned to help patients who have or are at risk for food allergies avoid a lifetime of managing the substantial burden associated with avoiding the allergen and coping with the consequences of accidental exposures.
Moderators: Edwin H. Kim, MD, FACAAI, and Douglas Jones, MD, FACAAI
11:30 am
Welcome and Introductions
Edwin H. Kim, MD, MS, FACAAI
11:35 am
Understanding the Safety of Food Allergy Therapy
Jonathan Hourihane, MD
11:50 am
Outcomes and Documentation: Choosing Wisely
Aikaterini (Katherine) Anagnostou, MD, PhD, FACAAI
12:05 pm
Implementation of Food Allergy Therapy in a Clinical Practice Setting
Douglas P. Mack, MSc, MD
12:20 pm
Choosing the Optimal Candidate: Considerations for Conversations With Families
Warner W. Carr, MD, FACAAI
12:35 pm
Questions and Discussion
Douglas Jones, MD, FACAAI
A recording of this session will be available after the Annual Meeting on the College Learning Connection. |
|
Moderator:
Edwin H. Kim, MD, FACAAI
Moderator:
Douglas H. Jones, MD, FACAAI
Speaker:
Douglas Mack, MD, MSc
Speaker:
Aikaterini (Katherine) Anagnostou, MD, PhD, FACAAI
Speaker:
Jonathan Hourihane, MD
Speaker:
Warner W. Carr, MD, FACAAI
|
Food & Drug Allergy and GI Disorders
|
Symposium
|
1:00 PM - 2:30 PM
|
Don't Be Rash! Assessing Contact Dermatitis
From basic science to the clinical conundrums, this session will cover how to evaluate and manage patients with contact dermatitis.
Moderators: Sandra M. Gawchik, DO, FACAAI, and Stephanie Mawhirt, DO
1:00 pm
Welcome and Introductions
Sandra M. Gawchik, DO, FACAAI
Stephanie Mawhirt, DO
1:05 pm
Histopathology of Allergic and Irritant Contact Dermatitis
Whitney A. High, MD, MEng
1:30 pm
Clinical Pearls and Pitfalls in Evaluating Patients With Contact Dermatitis
Sharon E. Jacob, MD
1:55 pm
Beyond Soap: How to Help Patients With Contact Dermatitis
Sandy Skotnicki, MD
2:20 pm
Questions and Discussion
|
|
Moderator:
Sandra M. Gawchik, DO, FACAAI
Moderator:
Stephanie Mawhirt, DO
Speaker:
Whitney A. High, MD, MEng
Speaker:
Sharon E. Jacob, MD
Speaker:
Sandy Skotnicki, MD
|
Dermatology
|
Interdisciplinary Panel Session
|
Pearls to Improve Your Practice Operations
Limit 45. Seats Available on first-come, first-served basis.
Every allergy practice can benefit from these pearls to help improve how your practice operates. Choose three of the five topics and spend 25 minutes with each expert addressing an aspect of allergy practice. The expert will give a five-minute overview of the topic and will then answer questions and facilitate discussion with the table participants for 20 minutes.
Table Rotations: 1:05 am, 1:30 am, 2:00 pm
Moderator: Stanley M. Fineman, MD, MBA, FACAAI
1:00 pm
Welcome and Introductions
Stanley M. Fineman, MD, MBA, FACAAI
Table 1
How Can Cash Flow / Revenue Cycle Management Help Our Bottom Line?
Scott McCutcheon, MHA
Table 2
Coding and Billing
Gary N. Gross, MD, FACAAI
Table 3
How Can You Add Additional Revenue Services in A/I Practice?
Jean Owen, MBA
Table 4
Should I Buy and Bill for Biologics?
James M. Tracy, DO, FACAAI
Table 5
A Novel Use of a CRNP as a Team With a Doctor (As Opposed to Working Independently)
J. Wesley Sublett, MD, MPH, FACAAI
|
|
Moderator:
Stanley M. Fineman, MD, MBA, FACAAI
Speaker:
Scott McCutcheon, MHA
Speaker:
Gary N. Gross, MD, FACAAI
Speaker:
Jean Owen, MBA
Speaker:
James M. Tracy, DO, FACAAI
Speaker:
J. Wesley Sublett, MD, MPH, FACAAI
|
Practice Management / Professional Issues
|
Ask the Expert Roundtables
|
2:00 PM - 6:00 PM
|
Exhibit Hall Open
|
|
|
|
College Resource Center Open in Exhibit Hall
|
|
|
|
2:30 PM - 3:00 PM
|
Refreshment Break in Exhibit Hall
Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc. |
|
|
|
|
3:00 PM - 4:30 PM
|
Evidence-based Diagnosis of Food Allergy
ARS
With the advent of commercial peanut allergy therapy, making a basic diagnosis of peanut allergy is essential. However, new and emerging diagnostic tests may complicate this process, and clinicians must be up-to-date on the indications for testing, what test to choose and how to interpret these tests. This session will review the current state of peanut allergy diagnostic testing, including potential applications of component testing and whether diagnostic testing can be used to infer future risk.
Moderators: Jay M. Portnoy, MD, FACAAI, and David B.K. Golden, MD, FACAAI
3:00 pm
Welcome and Introductions
Jay M. Portnoy, MD, FACAAI
David B.K. Golden, MD, FACAAI
3:05 pm
The Role of Skin Prick and Serum IgE Testing
Julie Wang, MD, FACAAI
In the patient presenting for evaluation of suspected peanut allergy, what are the indications to perform or not perform a diagnostic test (skin prick test or serum-specific IgE test) to help confirm peanut allergy?
3:35 pm
The Role of Component Testing
Matthew Greenhawt, MD, MBA, MSc, FACAAI
In the patient presenting for evaluation of suspected peanut allergy, does testing for peanut components, in addition to either skin and/or serum-specific IgE testing, increase diagnostic accuracy?
4:05 pm
Can We Predict the Likelihood or Severity of Allergic Reactions?
Marcus Shaker, MD, FACAAI
In the patient presenting for evaluation of suspected peanut allergy, can the results of a diagnostic test be used to predict the likelihood and/or severity of an allergic reaction?
|
|
Moderator:
Jay M. Portnoy, MD, FACAAI
Moderator:
David B.K. Golden, MD, FACAAI
Speaker:
Julie Wang, MD, FACAAI
Speaker:
Matthew Greenhawt, MD, MSc, MBA, FACAAI
Speaker:
Marcus Shaker, MD, MSc, FACAAI
|
Food & Drug Allergy and GI Disorders
|
Clinical Conundrum
|
Physician Health and Wellness: Advocating for Ourselves
MOC/CME
Provider health and wellness involves multiple issues, including provider stress, burnout and depression, which can lead to medical errors, early retirement, addiction, divorce and suicide. It has been shown that burnout issues start in medical school and progress through residency, fellowship and throughout a provider’s career. Many medical schools, residencies and allergy/immunology fellowships do not spend a lot of time on this issue during training, and, given the modern health care climate, physician/provider health and wellness is likely to continue becoming a more significant issue. This symposium will review the scientific literature about provider health and wellness and discuss the major causes of provider burnout and stress, along with potential solutions to alleviate this burden. Specific data regarding this topic among allergists/immunologists will be reviewed. This session can help allergy/immunology providers throughout their careers.
Moderators: Travis A. Miller, MD, FACAAI, and Andrew Nickels, MD, FACAAI
3:00 pm
Welcome and Introductions
Travis A. Miller, MD, FACAAI
Andrew Nickels, MD
3:05 pm
Compare and Contrast Potential Solutions to Provider Stress and Burnout, Specifically With Regards to Allergy and Immunology Providers
Maeve O'Connor, MD, FACAAI
3:30 pm
Health and Wellness Among Allergists and Immunologists: What Does the Data Show?
Gailen D. Marshall Jr., MD, PhD, FACAAI
3:55 pm
Ways to Reduce Burnout and Stress in the Practice Setting
Anil Nanda, MD, FACAAI
4:20 pm
Questions and Discussion
|
|
Moderator:
Travis A. Miller, MD, FACAAI
Moderator:
Andrew Nickels, MD
Speaker:
Maeve E. O'Connor, MD, FACAAI
Speaker:
Gailen D. Marshall, MD, PhD, FACAAI
Speaker:
Anil Nanda, MD, FACAAI
|
Environmental and Integrative Medicine
|
Symposium
|
3:00 PM - 6:00 PM
|
E-posters – Meet the Authors: Session 1
Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.
Not For Credit |
|
Moderator:
Brian T. Kelly, MD, MA
|
|
|
4:30 PM - 6:00 PM
|
American Association of Allergists and Immunologists of Indian Origin (AAAII) Annual Meeting and Symposium
|
|
|
|
4:45 PM - 6:00 PM
|
Advanced Practice, Allied Health and Office Administrators Networking Reception
Supported by Aimmune Therapeutics |
|
|
|
|
6:00 PM - 7:30 PM
|
President’s Welcome Reception
Supported by Aimmune Therapeutics
All registered attendees are invited to the ACAAI President’s Welcome Reception. Join us at Minute Maid Park, home of the Houston Astros! The main event will be in the park’s Union Station lobby, the grand entrance to Minute Maid Park, with an open bar and great food. You’ll get a great view of the field by stepping into areas of the covered concourse level and will have access to the infield warning track and dugouts. View the World Series trophy on the warning track by home plate from 6:00 – 7:00 pm. It all adds up to a home-run event!
Minute Maid Park is walking distance from the hotels. Transportation will not be provided. Enter ballpark at the Atrium Entrance off of Texas Street. Name badges must be worn for admittance to ballpark. |
|
|
|
|
8:00 PM - 10:00 PM
|
Non-CME Corporate Forum: A VR View: Severe Uncontrolled Asthma: Phenotypes, Endotypes, and Treatment Response Decisions
Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.
Not For Credit
Presented by:
Michael Wechsler, MD
Please join us on November 8 at 8:15pm as Michael Wechsler, MD of National Jewish Health in Denver presents a Non-CME program titled, A VR View: Severe Uncontrolled Asthma: Phenotypes, Endotypes, and Treatment Response Decisions. This program will include VR animations and will be of interest to any clinician who manages moderate-to-severe asthma.
Also, visit Sanofi Genzyme and Regeneron Pharmaceuticals, Inc. at Booth #313. |
|
|
|
|
Non-CME Corporate Forum: Today’s Allergy Immunotherapy Candidate: How SLIT Tablets May Expand the Use of AIT
Supported by ALK Inc.
Not For Credit
Presented by:
Don Bukstein, MD
Moises Calderon, MD
Brian Stone, MD
Tonya Winters
ALK-Abelló, Inc. will host a dessert reception, which includes 4 mini-presentations that illustrate today’s AIT candidate, monotherapy for polysensitized patients, realworld experience of SLIT-tablets, and expanding AIT in your practice to more patients.
$25 donations will be made to the Fellows-in-Training Travel Scholarship Fund through the American College of Allergy, Asthma & Immunology’s Foundation and to Allergy & Asthma Network for each participant attending all 4 mini-presentations.
Also, visit ALK Inc. at Booth #513. |
|
|
|
|